Cover Image

Pharmacotherapics Advice in Guidelines for COVID-19

Since December 2019 to May 2020, coronavirus disease 2019 (COVID-19) has infected over 6 million people worldwide. Due to its sudden and rapid outbreak, effective treatment for COVID-19 is scarce. Based on national clinical trials of novel treatments, China, Italy, Germany, and other countries and o...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhang-Ren Chen (Author), Ying Zhou (Author), Jin Liu (Author), Hong-Wei Peng (Author), Jian Zhou (Author), Hai-Li Zhong (Author), Li-Li Liu (Author), Ming-Fang Lai (Author), Xiao-Hua Wei (Author), Jin-Hua Wen (Author)
Format: Book
Published: Frontiers Media S.A., 2020-06-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Since December 2019 to May 2020, coronavirus disease 2019 (COVID-19) has infected over 6 million people worldwide. Due to its sudden and rapid outbreak, effective treatment for COVID-19 is scarce. Based on national clinical trials of novel treatments, China, Italy, Germany, and other countries and organizations have published multiple guidelines for COVID-19 and advised many medicines, such as chloroquine and tocilizumab. In this paper, we summarize the pharmacotherapy for COVID-19 according to those guidelines, highlight updates of the pharmacotherapy guidelines, and review the efficacy and safety of the indicated anti-COVID-19 drugs.
Item Description:1663-9812
10.3389/fphar.2020.00950

Similar Items